KLK3 and metabolic syndrome: Furthermore, since our institutional routine health check-ups were performed annually and former researches have reported that after 6 months of 5-ARIs treatment the serum PSA levels will be reduced by half 53, using a PSA of >1.4 ng/mL rather than the explicit history of medication treatment would also lower the detection rates of clinical BPH both in subjects with and without MetS.